Valproic acid Terminated Phase 2 Trials for Chronic Lymphocytic Leukaemia (CLL) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00524667HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia